MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

20 May 2024 Evaluate
Net sales declined -19.79%  to  Rs. 115.50 million from Rs. 144.00 millions.Profit after Tax for the quarter ended March 2024 saw a decline of -65.80% from Rs. 20.38 millions to Rs. 6.97  millions.Operating Profit reported a sharp decline to 53.38 millions from 71.26 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 115.50 144.00 -19.79 448.81 516.22 -13.06 448.81 516.22 -13.06
Other Income 0.09 0.20 -55.00 0.39 0.36 8.33 0.39 0.36 8.33
PBIDT 53.38 71.26 -25.09 211.23 215.23 -1.86 211.23 215.23 -1.86
Interest 15.18 20.14 -24.63 77.78 76.51 1.66 77.78 76.51 1.66
PBDT 38.20 51.12 -25.27 133.45 138.72 -3.80 133.45 138.72 -3.80
Depreciation 24.26 22.60 7.35 92.91 92.66 0.27 92.91 92.66 0.27
PBT 13.94 28.52 -51.12 40.54 46.06 -11.98 40.54 46.06 -11.98
TAX 6.97 8.14 -14.37 15.33 19.72 -22.26 15.33 19.72 -22.26
Deferred Tax -0.32 0.78 -141.03 -1.43 9.41 -115.20 -1.43 9.41 -115.20
PAT 6.97 20.38 -65.80 25.21 26.34 -4.29 25.21 26.34 -4.29
Equity 149.04 149.04 0.00 149.04 149.04 0.00 149.04 149.04 0.00
PBIDTM(%) 46.22 49.49 -6.61 47.06 41.69 12.88 47.06 41.69 12.88
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..